111462-38-5

Basic information

• Product Name: 1-O-benzyl-3,4-O-isopropylidene-D-erythritol ⁽¹²⁾ and 2-O-benzyl-3,4-O-isopropylidene-D-erythritol
• Synonyms: 1-O-benzyl-3,4-O-isopropylidene-D-erythritol ⁽¹²⁾ and 2-O-benzyl-3,4-O-isopropylidene-D-erythritol
• CAS NO: 111462-38-5
• Molecular Weight: 252.31
• Mol File: 111462-38-5.mol
• Article Data: 12

Chemical Properties

• CAS DataBase Reference: 1-O-benzyl-3,4-O-isopropylidene-D-erythritol ⁽¹²⁾ and 2-O-benzyl-3,4-O-isopropylidene-D-erythritol(CAS DataBase Reference)
• NIST Chemistry Reference: 1-O-benzyl-3,4-O-isopropylidene-D-erythritol ⁽¹²⁾ and 2-O-benzyl-3,4-O-isopropylidene-D-erythritol(111462-38-5)
• EPA Substance Registry System: 1-O-benzyl-3,4-O-isopropylidene-D-erythritol ⁽¹²⁾ and 2-O-benzyl-3,4-O-isopropylidene-D-erythritol(111462-38-5)

Safety Data

• Hazardous Substances Data: 111462-38-5(Hazardous Substances Data)

Upstream product

• 103795-12-6 (R)-2-(benzyloxy)-2-[(R)-2,2-dimethyl-1,3-dioxolan-4-yl]acetaldehyde 
• 127530-03-4 methyl 2-deoxy-3,4;5,6-di-O-isopropylidene-D-arabino-hexonate 
• 84379-51-1 dl-2-O-benzylerythritol 
• 77-76-9 2,2-dimethoxy-propane 
• 127529-99-1 (S)-Chloro-((4R,5S,4'R)-2,2,2',2'-tetramethyl-[4,4']bi[[1,3]dioxolanyl]-5-yl)-acetic acid methyl ester 
• 124909-02-0 2-O-benzyl-erythrobutanetetrol 
• 67-64-1 acetone 
• 100-39-0 benzyl bromide 
• 111462-37-4 Oxalic acid (R)-((R)-2,2-dimethyl-[1,3]dioxolan-4-yl)-methoxycarbonyl-methyl ester methyl ester 
• 38270-70-1 dimethyl meso-2,3-O-benzylidenetartrate 
• 100-52-7 benzaldehyde 
• 91274-05-4 (2S,3S)-1,2-O-isopropylidene-1,2,3,4-tetrol 
• 114184-97-3 (S)-1-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)ethane-1,2-diol 
• 121964-07-6 2,3-di-O-benzyl-4,5-O-isopropylidene-D-arabinitol 

Downstream Products

• 1310460-71-9 2-O-benzyl-1-O-(p-methoxybenzyl)-D-erythritol 
• 1310460-72-0 3,4-anhydro-2-O-benzyl-1-O-(p-methoxybenzyl)-D-erythritol 
• 1310460-69-5 2-O-benzyl-1-O-(p-methoxybenzyl)-3,4-O-isopropylidene-D-erythritol 
• 1584709-92-1 C₂₆H₃₁FN₂O₄ 
• 1584709-91-0 C₂₆H₃₀Cl₂N₂O₄ 
• 1584709-90-9 C₂₆H₃₂N₂O₄ 
• 1584709-89-6 C₂₇H₃₄N₂O₄ 
• 1584709-88-5 C₂₆H₃₁ClN₂O₄ 
• 1584709-66-9 (S)-3-(benzyloxy)-3-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-1-(4-fluorophenyl)propan-1-one 
• 1584709-65-8 (S)-3-(benzyloxy)-1-(3,4-dichlorophenyl)-3-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)propan-1-one 
• 1584709-64-7 (S)-3-(benzyloxy)-3-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-1-phenylpropan-1-one 
• 1584709-63-6 (S)-3-(benzyloxy)-3-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-1-(p-tolyl)propan-1-one 
• 1584709-62-5 (S)-3-(benzyloxy)-1-(4-chlorophenyl)-3-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)propan-1-one 
• 1584709-69-2 (R)-4-((R)-1-(benzyloxy)-2-bromoethyl)-2,2-dimethyl-1,3-dioxolane 

Relevant articles and documents

Total synthesis and the anticancer activity of (+)-spisulosine

The total synthesis of the anticancer agent (+)-spisulosine has been accomplished. The strategy involved a substrate-controlled aza-Claisen rearrangement to establish the erythro-configured amino-alcohol motif followed by deoxygenation to create a methyl

CYCLIC SULFONIUM SALT, PROCESS FOR PRODUCTION OF SAME, AND alpha-GLUCOSIDASE INHIBITOR COMPRISING SAME

Provided is a novel cyclic sulfonium salt compound which is useful for the prevention or treatment of diabetes and the like. The present invention relates to a novel cyclic sulfonium salt compound represented by general formula (I) or (II), an isomer or solvate of the compound, or a pharmaceutically acceptable salt of the compound or the isomer or solvate. The present invention also relates to an α-glucosidase inhibitor, a pharmaceutical composition for preventing or treating diabetes, and an anti-diabetes food, each of which comprises the compound represented by general formula (I) or (II) and the like.

The formal synthesis of 3-epi jaspine B using stereoselective intramolecular oxa-Michael addition

The formal synthesis of 3-epi jaspine B was achieved by using a stereoselective intramolecular oxa-Michael addition. The diacetate derivative of 3-epi jaspine B was also synthesized.